CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities
Net (loss) income	$ (651)	$ 907
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation expense	443	439
Amortization of intangibles	1,275	1,279
Debt issuance costs	198
Tax expense (benefit) from stock issuances	9	(193)
Amortization of deferred financing costs	38	38
Stock-based compensation	1,464	902
Change in fair value of contingent consideration	(35)
Changes in accounts receivable allowance	(93)	9
Deferred tax (benefit) provision	(500)	173
Loss on disposal of fixed assets	1	1
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	3,426	(1,432)
Prepaid expense and other current assets	(1,010)	(1,610)
Accounts payable	1,863	(1,046)
Deferred revenue	(975)	(84)
Accrued expenses	(3,191)	(1,579)
Net cash provided by (used in) operating activities	2,262	(2,196)
Cash flows from investing activities
Acquisitions net of cash acquired	(444)
Restricted cash	53	39
Purchase of furniture, fixtures and equipment	(583)	(290)
Net cash used in investing activities	(974)	(251)
Cash flows from financing activities
Principal payments on borrowings	(562)	(844)
Proceeds from issuance of ESPP shares	125	125
Payment of contingent consideration	(100)
Dividend paid		(5,189)
Debt issuance costs	9
Tax (expense) benefit from stock issuances	(9)	193
Equity securities repurchased	(945)	(978)
Net cash used in financing activities	(1,482)	(6,693)
Effect of exchange rate changes on cash	335	(1,312)
Net increase (decrease) in cash and cash equivalents	141	(10,452)
Cash and cash equivalents, beginning of period	17,835	27,662
Cash and cash equivalents, end of period	17,976	17,210
Noncash investing and financing activities:
Issuance of treasury stock for vested restricted stock awards and SARs	$ 1,753	$ 2,571